EXCESSIVE DAYTIME SLEEPINESS
Clinical trials for EXCESSIVE DAYTIME SLEEPINESS explained in plain language.
Never miss a new study
Get alerted when new EXCESSIVE DAYTIME SLEEPINESS trials appear
Sign up with your email to follow new studies for EXCESSIVE DAYTIME SLEEPINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic sleepiness: drug shows Long-Term promise
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug pitolisant for adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness. Participants had already completed a previous study of the same drug. The goal was to see if pitolisant rem…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug shows promise for reducing narcolepsy attacks over the long term
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who also have sudden muscle weakness (cataplexy) and severe daytime sleepiness. 68 people who had already completed an earlier study took AXS-12 and were monitored for s…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Sleep apnea drug shows promise for brain fog
Symptom relief CompletedThis study tested a drug called solriamfetol in 59 adults with obstructive sleep apnea who also had trouble thinking clearly and felt very sleepy during the day. The goal was to see if the drug could improve cognitive function, like attention and processing speed. Participants to…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE4 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 11, 2026 12:12 UTC
-
New pill aims to tame Narcolepsy's sudden collapses and crushing fatigue
Symptom relief CompletedThis study tested an investigational drug called AXS-12 in 90 people with narcolepsy who experience cataplexy (sudden muscle weakness) and excessive daytime sleepiness. The goal was to see if the drug could safely reduce the number of cataplexy attacks and improve alertness compa…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC